Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Carl Icahn Cuts Down Stake in Family Dollar Stores, Inc. (FDO)

The recent acquisition of Family Dollar Stores, Inc. (NYSE:FDO) by Dollar Tree, Inc. (NASDAQ:DLTR) in a cash and stock deal this week apparently has not pleased the billionaire activist investor, Carl Icahn. He was instrumental in putting pressure on Family Dollar Stores, Inc. (NYSE:FDO) to sell itself, though the company in its announcement mentioned that it was trying to find a suitable buyer even before Icahn made his thoughts public.

Carl Icahn

Icahn, who used to hold around 9.39% stake in Family Dollar Stores, Inc. (NYSE:FDO) has cut his exposure by nearly 35%, bringing his stake in the company down to around 6%.  Bertha Coombs reported this on CNBC, yesterday.

“We have got news on Carl Icahn reducing his stake in Family Dollar Stores, Inc. (NYSE:FDO). You will recall with the acquisition yesterday. His holdings were worth somewhere near 100 million in terms of the gain. He has reduced from 9.4% down to 6% in his latest 13D filing. Most, of course, Carl Icahn had pushed for a merger with Dollar General instead and he thought that would have been a better deal, but apparently he is going to take his capital now and deploy it better elsewhere, according to the filing,” Coombs said.

Disclosure: None

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!